Skip to main content
search

Late Clinical

Sign up

Latest resources

Featured resource

Upcoming late clinical webinars

Webinar

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

May 5, 2026 – 11am ET - 12pm ET
Webinar

Pharmacometrics Under Pressure

May 6, May 15 – 10:00 - 11:00am ET
Webinar

Explore Smarter, Faster PK/PD with Phoenix

May 12, 2026 – 10-11 AM ET/CET/JST

Latest late clinical blogs

Meet our experts at the following events

Live Events

Certara Biotech Forum: Workshop on Developing Investor-Ready Strategies

May 7, 2026 – San Diego, CA
Conference

ISPOR International Annual Conference 2026

May 17 - 20, 2026 – Philadelphia, PA
Conference

CDISC EU 2026

May 18 - 22, 2026 – Milan, Italy

All late clinical resources

Optimize Readiness for MHRA-NICE Aligned Pathway

Certara Services, Drug Development, Blog

Understanding LC/MS/MS

Certara Services, Blog, Knowledge Base

QSP at an Inflection Point: Scaling Impact

Certara Products - Certara IQ, Modeling and Simulation - QSP, Blog

From Models to Impact: What QSPC 2026 Revealed About the Future of Drug Development

Certara Products - Certara IQ, Certara Products - Simcyp, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, New Approach Methodologies (NAMs), Blog

DIDB® Concomitant Meds Navigator

Drug Development, Drug-Drug Interactions (DDI), Fact Sheet

3 Things You Should Know About ADaM Standards 

CDISC, Certara Products, Certara Products - Pinnacle 21, Data Standards, Blog

Top 10 Benefits of Simcyp® Simulator for Drug Development

Certara Products - Simcyp, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Blog

ADC Dose Optimization: Applying Model-Informed Strategies in Development

ADC, Biologics, Clinical Pharmacology, Clinical Trials, Drug Development, Drug Safety, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Blog

Mean Residence Time (MRT): Understanding How Long Drug Molecules Stay in the Body

Modeling and Simulation - PK/PD, Blog, Knowledge Base

Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access

ADC, Certara Services, Clinical Pharmacology, Drug Development, Modeling and Simulation, On-Demand Webinar

How Certara Enabled Fruquintinib FDA Approval for Metastatic Colorectal Cancer

Certara Services, Clinical Pharmacology, Clinical Trials, Drug Development, Model Informed Drug Development, Modeling and Simulation, Pharmacometrics, Therapeutic Specialties, Case Study

Final ICH M15 Guidance: Aligning MIDD with Global Regulatory Expectations

Certara Products, Certara Products - Phoenix, Certara Products - Simcyp, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Modeling and Simulation - PK/PD, Modeling and Simulation - QSP, Webinar
Sign up to newsletter

Why sign up? Because transforming drug development is not just our goal—it’s our obsession. If it’s yours too, then be the first to know of new insights and join us in pushing the boundaries of science.